A late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases.
Scholar Rock is a late-stage global biopharmaceutical company seeking a Medical Director/Sr Director, Clinical Research to drive clinical development activities for assigned product candidates.
A late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases.
Amylyx Pharmaceuticals